APA

Sonbol M. B., Hilal T., Dueck A. C., Rosenthal A. C., Conley C. R., Kosiorek H. E., Ginos B. F., Gano K. M., Nichols C. S., Leis J. F., Johnston P. B., Habermann T. M., Northfelt D. W., Bergsagel P. L., Inwards D. J., Witzig T. E., Ansell S. M. & Reeder C. B. (20190318). A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma. : Leukemia & lymphoma.

Chicago

Sonbol Mohamad Bassam, Hilal Talal, Dueck Amylou C, Rosenthal Allison C, Conley Christopher R, Kosiorek Heidi E, Ginos Brenda F, Gano Katherine M, Nichols Craig S, Leis Jose F, Johnston Patrick B, Habermann Thomas M, Northfelt Donald W, Bergsagel Peter Leif, Inwards David J, Witzig Thomas E, Ansell Stephen M and Reeder Craig B. 20190318. A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma. : Leukemia & lymphoma.

Harvard

Sonbol M. B., Hilal T., Dueck A. C., Rosenthal A. C., Conley C. R., Kosiorek H. E., Ginos B. F., Gano K. M., Nichols C. S., Leis J. F., Johnston P. B., Habermann T. M., Northfelt D. W., Bergsagel P. L., Inwards D. J., Witzig T. E., Ansell S. M. and Reeder C. B. (20190318). A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma. : Leukemia & lymphoma.

MLA

Sonbol Mohamad Bassam, Hilal Talal, Dueck Amylou C, Rosenthal Allison C, Conley Christopher R, Kosiorek Heidi E, Ginos Brenda F, Gano Katherine M, Nichols Craig S, Leis Jose F, Johnston Patrick B, Habermann Thomas M, Northfelt Donald W, Bergsagel Peter Leif, Inwards David J, Witzig Thomas E, Ansell Stephen M and Reeder Craig B. A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma. : Leukemia & lymphoma. 20190318.